• Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab

  • Aug 6 2020
  • Length: 24 mins
  • Podcast

Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab

Listen for free

View show details

  • Summary

  • In this podcast, Dr. Paul Studenic speaks to Dr. Sofia Ramiro and Prof. Robert Landewé both engaged in clinical work in the Zuyderland Medical Center in the south of the Netherlands about their clinical study evaluating systemic glucocorticoids and Il-6 blockade as second-line treatment for COVID-19-associated cytokine storm syndrome. They tell the story of the set-up of a peculiar trial using historical patients treated with supportive care as controls to the ‘experimental’ treatment strategy during these unprecedented times of March and April 2020. Link to article: https://ard.bmj.com/content/79/9/1143

    Link to EULAR press release: https://www.eular.org/sysModules/obxContent/files/www.eular.2015/1_42291DEB-50E5-49AE-5726D0FAAA83A7D4/eular_glucocorticoids_and_il_6_receptor_can_reduce_covid19_css_related_hospital_mortality_(002).pdf
    Show More Show Less
Show More Show Less

What listeners say about Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available